Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 3

1(20.0%)

5Total

N/A(4)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT05620173Not ApplicableActive Not Recruiting

Validation of New Virtual Reality Treatment for Children With Lazy Eye Using the Vedea Amblyopia Therapy (VAT)

Role: collaborator

NCT05633576Phase 3Recruiting

Steroid Eye Drops in Chronic Central Serous Chorioretinopathy

Role: collaborator

NCT05736042Not ApplicableUnknown

Microinterventional Endocapsular Nuclear Fragmentation Assisted Cataract Surgery

Role: lead

NCT05344651Not ApplicableRecruiting

Comparing the Baerveldt and Paul Glaucoma Drainage Devices and Their Effects on the Corneal Endothelium

Role: lead

NCT05500469Not ApplicableRecruiting

Endothelial Cell Loss in Pseudophakic Patients Receiving a Paul Glaucoma Drainage Device With Its Tube Inserted in the Anterior Versus Posterior Chamber: a Randomized Controlled Trial

Role: lead

All 5 trials loaded